Abstract
Mice depleted of γδ T cells by monoclonal antibody treatment and infected with Plasmodium berghei ANKA did not develop cerebral malaria (CM). In striking contrast, δ0/0 mice infected with P. berghei developed CM despite their γδ T-cell deficiency. γδ T cells appear to be essential for the pathogenesis of CM in mice having experienced normal ontogeny but not in mice genetically deprived of γδ T cells from the beginning of life.
The mechanisms whereby cells and molecules of the immune system function in immunity to malaria and the pathogenesis of this disease are ill-defined. Ho et al. (6) and others (13) have reported that humans with Plasmodium falciparum malaria exhibit a marked increase in the number of peripheral blood γδ T cells, which remain elevated for more than a month after cure. This observation led us to suggest that γδ T cells may exert a protective function during malaria. Subsequently we reported that cloned γδ T cells are cytotoxic for P. falciparum in vitro (3) and that γδ T cells are essential for the expression of cell-mediated immunity in vivo against the murine malarial parasite P. chabaudi (16).
Others have suggested that γδ T cells cause certain pathologic changes associated with malaria (10). Roussilhon et al. (14), for example, observed that human γδ T-cell clones in long-term cultures proliferate and exert cytotoxic activity in response to stimulation with autologous αβ T-cell clones. These authors contend that regulatory interactions occur between activated γδ T cells and αβ T cells during malaria and may lead to temporary immunodepression of αβ T-cell responses and the initial lymphocytopenia associated with infection. In addition, Perera et al. (11) reported that the severity of gastrointestinal symptoms in patients infected with P. vivax correlates with the number of γδ T cells in peripheral blood.
Although the exact role γδ T cells play in cerebral malaria (CM) has not yet been established, it is possible that these cells, which produce an array of cytokines, including gamma interferon (IFN-γ) and tumor necrosis factor alpha (9), may function in the pathogenesis of this disease. To address this possibility, we have examined the ability of P. berghei ANKA to produce CM in mice depleted of γδ T cells by antibody treatment or gene knockout (KO). We report here that the depletion of γδ T cells during adult life protects mice against CM; in contrast, mice genetically deprived of these cells throughout life develop CM when infected with P. berghei.
Pathogen-free male and female C57BL/6 mice (H-2b) were purchased from the Jackson Laboratory (Bar Harbor, Maine). Pathogen-free δ0/0 mice, which lack the δ chain of the γδ T-cell receptor (TCR) and thus lack detectable γδ T cells (7), were originally purchased from the same source and then were bred and maintained at the University of Wisconsin Gnotobiotic Laboratory (Madison, Wis.). These mice had a mixed 129/C57BL/6 (H-2b) genetic background and were predominantly of the C57BL/6 phenotype due to their four backcrosses to the C57BL/6 strain. Early in the study, we determined experimentally that both parental strains are highly susceptible to induction of CM by P. berghei ANKA, with 70 to 100% of mice infected with a dose of 106 parasitized erythrocytes manifesting this disease (unpublished data). Moreover, Yañez et al. reported earlier (17) that phenotypically normal heterozygote littermates to three other KO variants on the same 129/C57BL/6 background were also in this same susceptibility range (averaging 71% development of CM). We therefore routinely used C57BL/6 mice as controls in our experiments, because our breeding protocol for this particular KO (δ0/0 × δ0/0) did not generate heterozygous littermates. All mice used were between 6 and 8 weeks of age.
Infections with P. berghei parasites were initiated by intraperitoneal (i.p.) injection of blood containing 106 parasitized erythrocytes from a parasitized δ0/0 donor, as described previously (17). We chose this standardized inoculum because we have consistently observed that within the range of 105 to 107 parasitized erythrocytes, a few susceptible mice (10 to 30%) may not develop CM in any given group. Mice were sacrificed when they became moribund. Spleens were removed and prepared for flow cytometric analysis; brains were fixed in 10% neutral buffered formalin for histological examination. Mice were judged to have CM only if they displayed neurological signs (ataxia, seizures, and/or paralysis), became moribund within the first 2 weeks of infection (6 to 14 days postinoculation [p.i.]), and exhibited neurological lesions (hemorrhage, mononuclear cell accumulation within cerebral vessels, edema, and/or endothelial damage) upon histological examination of fixed, hematoxylin and eosin-stained sections of brain tissue (17). Parasitemia was assessed from Giemsa-stained thin smears of tail blood prepared every 3 to 4 days p.i.; the percentage of parasitized erythrocytes was determined by counting between 200 and 1,000 erythrocytes.
γδ T cells were depleted in vivo by treatment with TCR γδ-specific (hybridoma clone GL3) monoclonal antibody (MAb). High-performance liquid chromatography-purified hamster anti-TCR γδ MAb was injected i.p. into each C57BL/6 mouse (six mice per group) at a dose of 0.5 mg on days 0 and 4 p.i. A purified hamster immunoglobulin G (IgG) (Accurate Chemical & Scientific, Westbury, N.Y.) was injected identically into an equal number of C57BL/6 controls. The efficacy of γδ T-cell depletion in infected mice was determined by two-color flow cytometry of spleen lymphocytes, as described previously (4). On day 6 p.i. γδ T-cell-depleted P. berghei-infected C57BL/6 mice showed <0.01% splenic γδ T cells compared to 0.60% in hamster Ig-treated controls. Mice (three per group) were also depleted of γδ T cells with a single dose (0.8 mg) of anti-TCR γδ injected at different times during the course of infection. Control mice were injected with the same dose of hamster Ig. Other mice (three per group) were depleted of CD4+ or CD8+ T cells with a CD4-specific (hybridoma clone GK 1.5) or CD8-specific (hybridoma clone 2.43) MAb with a dose of 0.7 mg/mouse. Rat Ig (0.7 mg/mouse; Accurate Chemical & Scientific), was injected i.p. into control mice. All monoclonal antibodies were kindly provided by C. Czuprynski (University of Wisconsin, Madison).
The pattern of death in mice infected with P. berghei is known to be biphasic: mice either die within the first 2 weeks of infection with CM, or they die after 3 to 4 weeks of infection with severe anemia and hyperparasitemia, but no neurological manifestations (1). We observed that nearly all infected mice treated with hamster Ig became moribund with CM by day 7 p.i. In contrast, none of the mice depleted of γδ T cells developed CM (Table 1), but instead they became moribund without pathological signs of CM after day 21 p.i. Moreover, histological signs of CM were never observed in the brains of mice that had been depleted of γδ T cells, whether sacrificed on day 7 p.i. or on the day of moribundity after day 21 p.i., when these mice were severely anemic and hyperparasitiemic.
TABLE 1.
Effects of γδ T-cell depletion on the development of CM in mice infected with P. berghei ANKA
Mice were infected i.p. with 106 erythrocytes parasitized with P. berghei ANKA 2 h prior to the inoculation with MAb or rat Ig. Mice were injected i.p. with 0.5 mg of MAb GL-3 or hamster Ig on days 0 and 4 p.i.
Number of mice with CM/number of mice inoculated.
Mice were next depleted of γδ T cells at different times during the course of P. berghei infection with a single dose of MAb to determine the time at which these cells participate in the development of CM. For comparative purposes, other mice were depleted of CD4+ or CD8+ T cells; both T-cell subsets are crucial for the pathogenesis of P. berghei-induced CM (17). The results in Table 2 suggest that γδ T cells as well as CD4+ or CD8+ T cells function prior to day 5 of infection. A second mouse model deficient in γδ T cells, the δ0/0 mouse, was examined for its ability to resist development of CM when infected with P. berghei ANKA. Although none of the adult mice depleted of γδ T cells by antibody treatment before day 5 of infection ever showed any physical or histologic evidence of CM, a substantial number (12 of 28 [54%]) of the γδ T-cell-deficient KO mice developed CM that was easily recognizable by physical signs and clearly verifiable histologically.
TABLE 2.
Development of CM in mice depleted of γδ T cells at different times during the course of P. berghei malaria
| Treatment | CM/inoculated at daya:
|
||
|---|---|---|---|
| 0 | 3 | 5 | |
| Anti-TCR γδb | 0/3 | 0/3 | 2/3 |
| Hamster Ig | 2/3 | 2/3 | 2/3 |
| Anti-CD4c | 0/3 | 0/3 | 2/3 |
| Anti-CD8 | 0/3 | 0/3 | 2/3 |
| Rat Ig | 2/3 | 2/3 | 2/3 |
Mice were infected i.p. with 106 erythrocytes parasitized with P. berghei ANKA 2 h prior to inoculation with MAb or rat Ig. Results are given as number of mice with CM/number of mice inoculated and were determined at the indicated day (p.i.) of MAb treatment.
A single dose of anti-TCR γδ, 0.8 mg per mouse, was injected i.p. Hamster Ig at the same dose was injected into control mice.
A single dose of anti-CD4 or anti-CD8, 0.7 mg/mouse, was injected i.p. Rat Ig at the same dose was injected into control mice.
Our current findings indicate that γδ T cells, in addition to CD4+ and CD8+ T cells, have an essential function in the pathogenesis of CM. Although the relationship between these T-cell subsets remains to be determined, the results of our depletion studies at different times during infection suggest that they all function within several days after the initiation of infection. Unfortunately, the depletion of T-cell subsets at the times we chose does not permit us to determine whether these subsets function in a synergistic fashion or independently. We have observed that the activation of γδ T cells during experimental P. chabaudi malaria is dependent upon the presence of CD4+ T cells (15). CD4+ T cells activated by malarial antigens appear to produce cytokines that activate γδ T cells to proliferate and function in protective cell-mediated immunity against this parasite (2, 16). In contrast, others have suggested that γδ T cells function as components of the innate immune system (4, 8). When stimulated by pathogens, these cells act as a first line of defense and are thought to function by cytokine activation of cells of the adaptive immune response in a manner analogous to activation by NK cells. γδ T cells produce IFN-γ and tumor necrosis factor alpha in response to stimulation with different antigens (9) and appear to be the major source of IFN-γ when human peripheral blood mononuclear cells are cultured in the presence of P. falciparum antigens (12). Our observation that γδ T cells appear to function early during infection at a time when little if any proliferation of the γδ T-cell subset has occurred suggests that they may act in a similar capacity, i.e., as helper or stimulating cells rather than as effector cells in the pathogenesis of CM. Although the mechanisms remain to be determined, IFN-γ appears to be essential for the development of CM (5, 12, 17); it is possible that γδ T cells activated by malarial antigens early during infection secrete IFN-γ, which initiates events leading to disease.
The results of our studies with δ0/0 mice were unexpected (Table 3). About half of the γδ T-cell-deficient mice in each of two experiments developed CM when infected with P. berghei ANKA. These mice, which lack γδ T cells throughout life, may develop compensatory cells that eventually contribute to the pathogenesis of CM. It seems possible that under certain circumstances, different T-cell subsets or combinations of subsets may function independently of each other to produce disease. Whether γδ T cells have an essential function in the pathogenesis of human CM remains to be determined. However, should they have such a function, the deletion of γδ T cells or the neutralization of crucial cytokines secreted by γδ T cells could provide a new approach to the therapy of human CM, particularly if such therapy can be initiated before or immediately after recognition of the first signs of this disease. The finding that the depletion of γδ T cells from otherwise intact mice prevents the development of CM during P. berghei infection provides a model in which to analyze mechanisms by which these cells function in the pathogenesis of this disease.
TABLE 3.
CM in δ0/0 mice infected with P. berghei ANKA
| Expt no. | Exptl group | CM/inoculateda |
|---|---|---|
| 1 | δ0/0 mouse | 6/12 |
| C57BL/6 control | 9/9 | |
| 2 | δ0/0 mouse | 9/16 |
| C57BL/6 control | 6/6 |
Mice were infected i.p. with 106 erythrocytes parasitized with P. berghei ANKA. Results are given as number of mice with CM/number of mice inoculated.
Acknowledgments
We thank A. J. Cooley, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin—Madison, for teaching us how to evaluate the pathological changes of cerebral malaria.
This work was supported by Public Health Service grant AI 12710.
REFERENCES
- 1.Curfs J H A, van der Meide P H, Billiau A, Meuwissen J H E T, Eling W M. Plasmodium berghei: recombinant interferon-γ and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol. 1993;77:212–223. doi: 10.1006/expr.1993.1078. [DOI] [PubMed] [Google Scholar]
- 2.Elloso M M, van der Heyde H C, Troutt A, Manning D D, Weidanz W P. Human γδ T cell subset proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of IL-2R. J Immunol. 1996;157:2096–2101. [PubMed] [Google Scholar]
- 3.Elloso M M, van der Heyde H C, vandeWaa J A, Manning D D, Weidanz W P. Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells. J Immunol. 1994;153:1187–1194. [PubMed] [Google Scholar]
- 4.Ferrick D A, Schrenzel M D, Mulvania T, Itseih B, Ferlin W G, Lepper H. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo. Nature. 1995;373:255–257. doi: 10.1038/373255a0. [DOI] [PubMed] [Google Scholar]
- 5.Grau G E, Hermans H, Piqùet P F, Pointaire P, Lambert P H, Billian A, Vassilli P. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA. 1989;86:5572–5574. doi: 10.1073/pnas.86.14.5572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ho M, Webster H K, Tonqtacoe P, Pattanapanyasat K, Weidanz W P. Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol Lett. 1990;25:139–142. doi: 10.1016/0165-2478(90)90105-y. [DOI] [PubMed] [Google Scholar]
- 7.Itohara S, Mombaerts P, Lafaille J, Iacomini J, Nelson A, Clarke A R, Hooper M-L, Farr A, Tonegawa S. T cell receptor γδ gene mutant mice: independent generation of αβ T cells and programmed rearrangement of γδ TCR genes. Cell. 1993;72:337–348. doi: 10.1016/0092-8674(93)90112-4. [DOI] [PubMed] [Google Scholar]
- 8.Janeway C A. Frontiers of the immune system. Nature. 1988;373:255–257. doi: 10.1038/333804a0. [DOI] [PubMed] [Google Scholar]
- 9.Kaufmann S H E. δ/γ and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA. 1996;93:2272–2279. doi: 10.1073/pnas.93.6.2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Langhorne J, Goodier M, Behr C, Dubois P. Is there a role for γδ T cells in malaria? Immunol Today. 1992;13:298–300. doi: 10.1016/0167-5699(92)90041-5. [DOI] [PubMed] [Google Scholar]
- 11.Perera M K, Carter R, Goonewardene R, Mendis K N. Transient increase in circulating γδ T cells during Plasmodium vivax paroxysms. J Exp Med. 1994;179:311–315. doi: 10.1084/jem.179.1.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pichyangkul S, Saengkrai P, Yongvanitchit K, Stewart A, Heppner D G. Activation of gamma delta T cells in malaria: interaction of cytokines and a schizont-associated Plasmodium falciparum antigen. J Infect Dis. 1997;1:233–241. doi: 10.1086/514029. [DOI] [PubMed] [Google Scholar]
- 13.Roussilhon C, Agrapart M, Ballet J J, Bensussan A. T lymphocytes bearing gamma delta T cell receptor in patients with acute Plasmodium falciparum malaria. J Infect Dis. 1990;162:283–285. doi: 10.1093/infdis/162.1.283-a. [DOI] [PubMed] [Google Scholar]
- 14.Roussilhon C, Agrapart M, Guglielmi P, Bensussan A, Brasseur P, Ballet J J. Human TcRγδ+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol. 1994;95:91–97. doi: 10.1111/j.1365-2249.1994.tb06020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.van der Heyde H C, Manning D D, Weidanz W P. Role of CD4+ T cells in the expansion of the CD4−, CD8−, γδ T cell subset in the spleens of mice during blood-stage malaria. J Immunol. 1993;151:6311–6317. [PubMed] [Google Scholar]
- 16.van der Heyde H C, Elloso M M, Chang W-L, Kaplan M, Manning D D, Weidanz W P. Gamma delta T cell function in cell-mediated immunity to acute blood stage Plasmodium chabaudi adami malaria. J Immunol. 1995;154:3985–3990. [PubMed] [Google Scholar]
- 17.Yañez D, Manning D D, Cooley A J, Weidanz W P, van der Heyde H C. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol. 1996;157:1620–1624. [PubMed] [Google Scholar]